Amit Kumthekar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amit Kumthekar has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Aaron L. Misakian
Department of Pediatrics, Division of Endocrinology, Stanford School of Medicine, Stanford, CA 94305, USA
1 shared publication - Amy Barrett
Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ, UK
1 shared publication - Ananta Addala
Department of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, California, USA
1 shared publication - Anna L. Gloyn
Department of Pediatrics, Stanford School of Medicine, Stanford University, CA, USA
1 shared publication - Colleen Jodarski
Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA
1 shared publication - Cécile Saint-Martin
Department of Medical Genetics, AP-HP Pitié-Salpêtrière Hospital, Sorbonne University, 75012 Paris, France
1 shared publication
Latest Publications
- Open Access
- 23 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 156
Functional Characterization of Glucokinase Variants to Aid Clinical Interpretation of Monogenic Diabetes
Precision medicine starts with a precision diagnosis. Yet up to 80% of cases of monogenic diabetes, a form of diabetes characterized by mutations in a single gene, are either overlooked or misdiagnosed. A genetic test for monogenic diabetes does not always lead to a precise diagnosis, as novel variants are often classified as variants of unknown significance. Variant interpretation requires collation of a framework of evidence, including population, computational, and segregation data, and can be assisted by functional analysis. The inclusion of functional data can be challenging, depending on the number of benign and pathogenic variants available for benchmarking assays. Glucokinase is the rate-limiting step for glucose metabolism in the pancreatic beta-cell and governs the threshold for glucose-stimulated insulin release. Loss-of-function alleles in the glucokinase (GCK) gene are a cause of stable fasting hyperglycemia from birth and/or diabetes. In this study, we functionally characterized 25 variants identified during diagnostic testing or in exome sequencing studies. We assessed their kinetic characteristics, stability, and interaction with pharmacological and physiological regulators. We integrated our functional data with existing data from the ClinGen Monogenic Diabetes Variant Curation Expert Review panel using a gene-specific framework to assist variant classification. We show how functional evidence can aid variant classification, thus enabling diagnostic certainty.
- 23 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 156
Open AccessFunctional Characterization of Glucokinase Variants to Aid Clinical Interpretation of Monogenic Diabetes
Precision medicine starts with a precision diagnosis. Yet up to 80% of cases of monogenic diabetes, a form of diabetes characterized by mutations in a single gene, are either overlooked or misdiagnosed. A genetic test for monogenic diabetes does not always lead to a precise diagnosis, as novel variants are often classified as variants of unknown significance. Variant interpretation requires collation of a framework of evidence, including population, computational, and segregation data, and can be assisted by functional analysis. The inclusion of functional data can be challenging, depending on the number of benign and pathogenic variants available for benchmarking assays. Glucokinase is the rate-limiting step for glucose metabolism in the pancreatic beta-cell and governs the threshold for glucose-stimulated insulin release. Loss-of-function alleles in the glucokinase (GCK) gene are a cause of stable fasting hyperglycemia from birth and/or diabetes. In this study, we functionally characterized 25 variants identified during diagnostic testing or in exome sequencing studies. We assessed their kinetic characteristics, stability, and interaction with pharmacological and physiological regulators. We integrated our functional data with existing data from the ClinGen Monogenic Diabetes Variant Curation Expert Review panel using a gene-specific framework to assist variant classification. We show how functional evidence can aid variant classification, thus enabling diagnostic certainty.